Alpha 2.0
Login Register
» Articles » PMID: 12176410

Sirolimus Inhibits Growth of Human Hepatoma Cells in Contrast to Tacrolimus Which Promotes Cell Growth

Overview
Journal Transplant Proc
Specialty General Surgery
Date 2002 Aug 15
PMID 12176410
Citations 12
Authors
G Schumacher
M Oidtmann
S Rosewicz
J Langrehr
S Jonas
A R Mueller
A Rueggeberg
R Neuhaus
M Bahra
D Jacob
H Gerlach
P Neuhaus
Affiliations
Soon will be listed here.
Citing Articles

Update on Immunosuppression in Liver Transplantation.

Tasdogan B, Ma M, Simsek C, Saberi B, Gurakar A Euroasian J Hepatogastroenterol. 2020; 9(2):96-101.

PMID: 32117698 PMC: 7047305. DOI: 10.5005/jp-journals-10018-1301.

Assessing the role of everolimus in reducing hepatocellular carcinoma recurrence after living donor liver transplantation for patients within the UCSF criteria: re-inventing the role of mammalian target of rapamycin inhibitors.

Thorat A, Jeng L, Yang H, Yeh C, Hsu S, Chen T Ann Hepatobiliary Pancreat Surg. 2017; 21(4):205-211.

PMID: 29264583 PMC: 5736740. DOI: 10.14701/ahbps.2017.21.4.205.

Mammalian target of rapamycin inhibition in hepatocellular carcinoma.

Ashworth R, Wu J World J Hepatol. 2014; 6(11):776-82.

PMID: 25429315 PMC: 4243151. DOI: 10.4254/wjh.v6.i11.776.

Liver Transplantation for HCC: A Review.

Kakodkar R, Soin A Indian J Surg. 2013; 74(1):100-17.

PMID: 23372314 PMC: 3259181. DOI: 10.1007/s12262-011-0387-2.

Targeted therapy for hepatocellular carcinoma: novel agents on the horizon.

Cervello M, McCubrey J, Cusimano A, Lampiasi N, Azzolina A, Montalto G Oncotarget. 2012; 3(3):236-60.

PMID: 22470194 PMC: 3359882. DOI: 10.18632/oncotarget.466.